Retrospective Study
Copyright ©The Author(s) 2025.
World J Hepatol. Feb 27, 2025; 17(2): 101936
Published online Feb 27, 2025. doi: 10.4254/wjh.v17.i2.101936
Table 1 Sociodemographic, anthropometric, and clinical characteristics of patients with type 2 diabetes mellitus at Limbe Regional Hospital, n (%)
Variable
Total (n = 150)
NAFLD (n = 28)
No NAFLD (n = 122)
P value
Sex0.03
Male63 (42.0)10 (36.0)53 (43.0)
Female87 (58.0)18 (64.0)69 (57.0)
Age group (years)0.001
25-4022 (15.0)6 (21.0)16 (13.0)
41-6586 (57.0)16 (58.0)70 (57.0)
≥ 6642 (28.0)6 (21.0)36 (30.0)
Marital status< 0.001
Married81 (54.0)19 (68.0)62 (51.0)
Divorced38 (25.0)4 (14.0)34 (28.0)
Single11 (7.0)2 (7.0)9 (7.0)
Widowed20 (13.0)3 (11.0)17 (14.0)
Level of education< 0.001
Primary47 (31.0)11 (39.0)36 (29.0)
Secondary79 (53.0)16 (57.0)63 (57.0)
Tertiary24 (16.0)1 (4.0)23 (19.0)
Employment status< 0.001
Employed76 (50.7)13 (46.0)63 (52.0)
Unemployed74 (49.3)15 (54.0)59 (48.0)
Area of residence0.04
Rural58 (39)10 (36)48 (39)
Urban92 (61)18 (64)74 (61)
Waist circumference< 0.001
Centrally obese51 (34)20 (57)31 (25)
Non-obese99 (66)8 (29)91 (75)
Body mass index< 0.001
Underweight7 (5)0 (0)7 (6)
Normal weight88 (59)9 (32)79 (65)
Overweight55 (35)19 (68)36 (30)
Obese0 (0.0)0 (0.0)0 (0.00)
Consumption of vegetables0.02
< 3 times/week100 (67)12 (43)88 (72)
> 3 times/week50 (33)16 (57)34 (28)
Physical activity0.001
Insufficient64 (43)15 (57)49 (40)
Sufficient86 (57)13 (46)73 (60)
Family history< 0.001
No59 (39)12 (43)49 (40)
Yes91 (61)16 (57)73 (60)
Type of treatment< 0.001
Insulin10 (7)4 (14)6 (5)
Metformin55 (37)10 (36)45 (37)
Insulin + Metformin83 (55)12 (42)71 (58)
Others0 (0.0)2 (7)0 (0)
Table 2 Comparison of biochemical and clinical characteristics between patients with type 2 diabetes mellitus with and without non-alcoholic fatty liver disease, mean ± SD
Variable
Total (n = 150)
No NAFLD (n = 122)
NAFLD (n = 28)
t-test
P value
TG (mg/dL)102.23 ± 75.3386.19 ± 62.59173.68 ± 84.345.172< 0.001
GGT (U/L)42.71 ± 24.6637.36 ± 22.3165.27 ± 22.016.033< 0.001
HbA1c (%)5.15 ± 1.494.66 ± 0.987.82 ± 0.851.7800.085
WC (cm)75.96 ± 26.2571.94 ± 22.6592.29 ± 34.892.9460.006
BMI (kg/m2)24.49 ± 6.2224.81 ± 18.3230.08 ± 7.982.3490.021
Table 3 Factors associated with non-alcoholic fatty liver disease among patients with type 2 diabetes mellitus attending Limbe Regional Hospital
Explanatory variable
Crude odds ratio (95%CI)
P value
Adjusted odds ratio (95%CI)
P value
SexMale4.357 (-)< 0.0011.824 (0.441-7.541)0.406
Female1 (-)-1 (-)-
Age group (years)25-404.357 (-)< 0.00115.701 (0.956-257.852)0.054
41-654.357 (-)< 0.0011.278 (0.134-12.212)0.831
≥ 661 (-)-1 (-)-
Marital statusMarried4.357 (-)< 0.0011.340 (0.128-14.043)0.807
Single4.357 (-)< 0.0010.321 (0.018-5.621)0.437
Divorced4.357 (-)< 0.0010.455 (0.023-8.842)0.603
Widow1 (-)-1 (-)-
ResidenceRural4.357 (-)< 0.0010.972 (0.260-3.634)0.967
Urban1 (-)-1 (-)-
Level of educationPrimary4.357 (-)< 0.00114.374 (0.869-237.818)0.063
Secondary4.357 (-)< 0.0014.616 (0.343-62.090)0.249
Tertiary1 (-)-1 (-)-
OccupationTrader4.357 (-)< 0.0013.762 (0.671-21.092)0.132
Teacher4.357 (-)< 0.0010.397 (0.052-3.023)0.372
Driver4.357 (-)< 0.0018.166 × 10^80.988
Farmer4.357 (-)< 0.0010.138 (0.005-3.635)0.235
Housewife4.357 (-)< 0.0013.565 (0.335-37.939)0.292
Others1 (-)-1 (-)-
Physical exerciseNo4.357 (-)< 0.0010.529 (0.116-2.418)0.411
Yes1 (-)-1 (-)-
Vegetable intake< 3 times/week4.357 (-)< 0.0010.131 (0.020-0.839)0.032
> 3 times/week1(-)-1 (-)-
Physical exerciseInsufficient4.357 (-)< 0.0010.529 (0.116-2.418)0.411
Sufficient1 (-)-1 (-)-
Vegetable intake< 3 times/week4.357 (-)< 0.0010.131 (0.020-0.839)0.032
> 3 times/week1(-)-1 (-)-
Central obesity (cm)Present4.357 (-)< 0.0010.167 (0.037-0.748)0.019
Absent1 (-)-1 (-)-
Body mass index (kg/m2)Underweight4.357 (-)< 0.0016.511 × 10^7 (0.000-NA)0.992
Overweight and obese4.357 (-)< 0.0010.917 (0.152-5.512)0.924
Normal weight1 (-)-1 (-)-
Family history of diabetesYes4.357 (-)< 0.0012.269 (0.557-9.252)0.253
No1 (-)-1 (-)-
Type of treatment for type 2 diabetes mellitusInsulin4.357 (-)< 0.0013.370 × 108 (4.204 × 109-2.702 × 107)< 0.001
Metformin4.357 (-)< 0.0010.167 (0.037-0.718)< 0.001
Insulin + Metformin4.357 (-)< 0.0015.856 × 109 (5.856 ×109-5.856 ×109)NA
Others1 (-)-1 (-)-
Duration of type 2 diabetes mellitus (years)1-104.357 (-)< 0.0010.898 (0.046-17.404)0.943
11-204.357 (-)< 0.0012.541 × 107 (0.000-NA)0.99
≥ 211 (-)-1 (-)-
Table 4 Comparison of biochemical and clinical characteristics between patients with good and poor glycemic control, mean ± SD
Variable
Total (n = 150)
Good control (n = 127)
Poor control (n = 23)
t-test
P value
TG (mg/dL)102.23 ± 75.3397.97 ± 74.56127.61 ± 74.69-1.7510.090
GGT (U/L)42.71 ± 24.6640.60 ± 24.2353.48 ± 25.08-2.2780.030
HbA1c (%)5.15 ± 1.494.66 ± 0.987.82 ± 0.85-16.036< 0.001
WC (cm)75.96 ± 26.2574.90 ± 25.7980.39 ± 30.12-0.8220.418
BMI (kg/m2)24.49 ± 6.2225.57 ± 18.1727.06 ± 7.64-0.6590.512
Table 5 Relationship between non-alcoholic fatty liver disease and glycemic control among patients with type 2 diabetes mellitus attending Limbe Regional Hospital, n (%)
Variable
No NAFLD
NAFLD
Total
χ2
P value
Glycemic control statusPoor (HbA1c ≥ 7 %)11 (9.0)16 (57.1)27 (15.3)20.089< 0.001
Good (HbA1c < 7 %)111 (91.0)
12 (42.9)123 (84.7)
Total122 (100.0)28 (100.0)150 (100.0)